Parkinson’s disease, often recognized primarily as a neurological condition, is increasingly being linked to the gut. Evidence suggests that gastrointestinal symptoms such as constipation might appear well before the more recognized motor symptoms, opening avenues for earlier diagnosis. Current research focuses on the gut microbiome’s influence and the role of the alpha-synuclein protein, though effective, gut-based treatments remain elusive.
